NCT04066062 is a clinical trial in Coronary Artery Disease, sponsored by Cleerly, Inc..

Who is sponsoring NCT04066062?

NCT04066062 is sponsored by Cleerly, Inc..

What condition does NCT04066062 study?

NCT04066062 studies Coronary Artery Disease.

Is NCT04066062 still recruiting?

NCT04066062 is currently active, enrolled. Last updated 26 November 2024.

Last reviewed 2024-11-26 · How we verify

NCT04066062

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Multicentre Registry of CCTA, IVUS and OCT

Active, enrolled Last updated 26 November 2024

What this trial tests

trial in Coronary Artery Disease in 1,700 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline

1 October 2019

Primary endpoint
31 December 2022

31 December 2025

Quick facts

Lead sponsor	Cleerly, Inc.
Status	Active, enrolled
Study type	OBSERVATIONAL
Enrollment	1,700
Start date	1 October 2019
Primary completion	31 December 2022
Estimated completion	31 December 2025
Sites	9 locations across Japan

Conditions studied

Coronary Artery Disease — all drugs for Coronary Artery Disease →

Sponsor

Cleerly, Inc. — full company profile →

Who can join

18 and older, any sex, with Coronary Artery Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The Invictus Registry will compare the diagnostic performance of coronary computed tomography angiography (CCTA) versus intravascular imaging by intravenous ultrasound (IVUS) or optical coherence tomography (OCT) for the measurement of minimum lumen area, the identification of stenosis severity, burden, morphology and vulnerability of coronary atherosclerosis.

Publications & conference data

4 peer-reviewed publications reference this trial (live from Europe PMC):

Rationale and design of the INVICTUS Registry: (Multicenter Registry of Invasive and Non-Invasive imaging modalities to compare Coronary Computed Tomography Angiography, Intravascular Ultrasound and Optical Coherence Tomography for the determination of Severity, Volume and Type o
Nakanishi R, Okubo R, Sobue Y, Kaneko U, et al · · 2023 · cited 9× · PMID 37679247 · DOI 10.1016/j.jcct.2023.08.011
Evolution or Revolution?: AI in Coronary CT Evaluation.
Branch KRH. · · 2024 · cited 2× · PMID 39372452 · DOI 10.1016/j.jacadv.2024.100860
Artificial intelligence-based coronary computed tomography angiography quantification of atherosclerosis burden: comparison with intravascular ultrasound in the INVICTUS Registry.
Nakanishi R, Okubo R, Matsuo H, Sobue Y, et al · · 2026 · PMID 41781729 · DOI 10.1007/s00330-026-12412-y
Artificial Intelligence in Computed Tomography Coronary Angiography.
Leung C. · · 2025 · PMID 41106892 · DOI 10.1016/j.jaccas.2025.105655

Verify or expand the search:

Other recruiting trials for Coronary Artery Disease

Currently open trials in the same condition.

NCT07399002 — LONG NAGOMI™ PMCF STUDY · recruiting
NCT07420582 — Antegrade Autologous Blood Reinfusion After CPB · recruiting
NCT07493603 — A Study on Yiyang Huoluo Decoction in the Treatment of Coronary Heart Disease · Phase 1, PHASE2 · recruiting
NCT06535568 — Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO · NA · recruiting
NCT07286578 — A Prospective, Multicenter, Randomized Controlled Trial to Investigate the Value of Coronary CT Angiography in the Under · NA · recruiting

Other Cleerly, Inc. trials

Trials by the same sponsor.

NCT06112418 — A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events · NA · recruiting
NCT04279496 — Coronary CT Angiography Evaluation for Clinical Outcomes: An International Multicenter Registry · enrolling by invitation

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04066062 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Cleerly, Inc.
Last refreshed: 26 November 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04066062.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing